echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > These pharmaceutical projects won the 2017 National Science and Technology Award

    These pharmaceutical projects won the 2017 National Science and Technology Award

    • Last Update: 2018-01-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: medical geography 2018-01-08 2017 National Science and technology award Conference opened today (January 8, 2018) in the Great Hall of the people A total of 271 projects and 9 people awards were selected, totaling 280 (people) Among them, Wang Zeshan, Professor of Nanjing University of science and technology, academician of Chinese Academy of engineering, Hou Yunde, researcher of Institute of Virology of China Center for Disease Control and prevention and academician of Chinese Academy of engineering, won the highest national science and technology award Medical geography has sorted out the list of awards related to medicine for you to see! 2017 National Natural Science Award: Research on new mechanism of interaction between HIV and host natural defense factors (second prize): Yu Xiaofang (Jilin University), Zhang Wenyan (Jilin University), Du Juan (Jilin University), Yu Xianghui (Jilin University), Zhao Ke (Jilin University) cellular calcium signal and molecular regulation (second prize) Main finishers: Wang Shiqiang (Peking University), Cheng Heping (Peking University), Xu Ming (the Third Hospital of Peking University), Wei Chaoliang (Peking University), Zhang Youyi (the Third Hospital of Peking University) glial cell neuron function coupling and ischemic brain protection (second prize) main finishers: Wang Wei (Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of science and Technology), Duan Shumin (Shanghai Institute of life sciences, Chinese Academy of Sciences), Han Jing (Shaanxi Normal University), Xie Minjie (Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of science and Technology), Zhang Min (Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of science and Technology) 2017 National Technology Invention Award Antofloxacin hydrochloride (second prize), a new national class 1.1 drug, was awarded by Yang Yushe (Shanghai Institute of pharmaceutical research, Chinese Academy of Sciences), Wang Xiang (Anhui Global Pharmaceutical Co., Ltd.), Jiang Hualiang (Shanghai Institute of pharmaceutical research, Chinese Academy of Sciences), Chen Kaixian (Shanghai Institute of pharmaceutical research, Chinese Academy of Sciences), Zhang Shu (Anhui Global Pharmaceutical Co., Ltd.), Ji Ruyun (Shanghai Institute of medicine, Chinese Academy of Sciences) 2017 National Science and Technology Progress Award for major innovation and technological breakthrough in the prevention and control of human infection with h7n9 avian influenza (Special Award) main achiever: Li Lanjuan, Shu Yuelong, Guan Yi, Feng Zijian, Yuan Guoyong, Gao Fu, Yuan Zhenghong, Wang Yu, Yu Hongjie, Wang Dayan, Gao hainv, Wang Chen, Zheng Shusen, Yang Shigui, Yang Weizhong, Cao Bin, Chen Honglin, Li Qun, Zhu Huachen, Zhou Jianfang, Liu Zhai, Gao Rongbao, Wu Nanping, Hu Yunwen, Yao hangping, Zhang Xi, Yu Liang, Zheng Shufa, Wu fan, Lu Hongzhou, Wang Jia, Xia Shichang, Cui Dawei, Bai Tian, Liang Weifeng, Lin Zanyu, Wu Guizhen, Jie Zhijun, Guo Jing, Du Qihong, Sheng Jifang, Diao Hongyan, Xiang nijuan, Yang Yida, Zhao Xiang, Tang Lingling, Zou Shumei, Yu Fei, Zhu Danhua; mainly completed by: the First Affiliated Hospital of Zhejiang University Medical College, Institute of viral disease control and prevention of China Center for Disease Control and prevention, China Center for Disease Control and prevention, Shantou University, Hong Kong University, Fudan University, Institute of microbiology of Chinese Academy of Sciences, Shanghai Center for Disease Control and prevention, Shanghai Fifth People's Hospital , Beijing Chaoyang Hospital Affiliated to Capital Medical University, Zhejiang Provincial Center for Disease Control and prevention series of popular science of kidney diseases (second prize) mainly completed by: Liu zhangsuo, Zhang Haitao, Liu Dongwei, Liu ZHENGZHAO, Liang Xianhui, Chen Min, Chen Wei, Yu Shengqiang, Zhao Zhanzheng, Li Guisen high efficiency sub package equipment and industrialization (second prize) Main completers: Tang Yue, Tao Bo, Ma Hongxu, Li Xinhua, Cai Dayu, Chen Jiankui, Li Jie, Yang Yuxiang, Xu Jian, Jiang Xiaoming; mainly completed by: truking science and Technology Co., Ltd., Huazhong University of science and technology, national defense science and Technology University of the people's Liberation Army, Jiangsu Hengrui Pharmaceutical Co., Ltd., humanwell Pharmaceutical Group Co., Ltd., Zhengda Tianqing Pharmaceutical Group Co., Ltd (second prize) Main completed by: Huang Xiaojun, Wang Yu, Liu Qifa, Zhang Xiaohui, Chang Yingjun, Zhao Xiangyu, Xu Lanping, Liu Kaiyan, Yan Chenhua, Mo Xiaodong; main completed by: People's Hospital of Peking University, Southern Hospital of Southern Medical University; main completed by: Wu Yilong, Mo Shujin, Cheng Ying, song Xiaodong Yong, Zhou Qing, Zhang xuchao, Zhong Wenzhao, Yang Jinji, Yang Xuening, Nie Qiang; mainly completed by: Guangdong People's Hospital (Guangdong Academy of Medical Sciences), Chinese University of Hong Kong, Jilin Cancer Hospital, Nanjing General Hospital of Nanjing Military Region of the people's Liberation Army key technology research and clinical application of precise radiotherapy for lung cancer (second prize) Main completed by: Li Baosheng, Yu Jinming, Shu Huazhong, Fu Xiaolong, Lu Bing, Huang Wei, Yin Yong, Yuan Shuanghu, Zhu Jian, Xing Ligang; main completed by: Shandong cancer prevention and treatment institute, Southeast University, Shanghai Chest Hospital, Guizhou Medical University; establishment and application of new discovery of endocrine tumor pathogenesis and clinical diagnosis and treatment technology (second prize) Mainly completed by: Wang Weiqing, ye Lei, Cao Yanan, Jiang Yiran, Su Weiwei, Zhou Weiwei, Jiang Lei, sun Shouyue, Zhu Wei, Ning Guang; mainly completed by: Ruijin Hospital Affiliated to Shanghai Jiaotong University School of medicine, Shanghai Institute of Endocrinology and metabolism, new strategy and technology for prevention and treatment of ischemic stroke and its promotion and application (second prize) Main completed by: Zhou Huadong, Xie Peng, Huang Jiaxing, Zhang Yonghong, Wang Longde, Wang Yanjiang, Chen Kangning, Fu Jianhui, Hua Yang, Zhang Meng; main completed by: the Third Military Medical University of the people's Liberation Army, Chongqing Medical University, Chinese University of Hong Kong, Suzhou University, Chinese Preventive Medicine Association, Huashan Hospital Affiliated to Fudan University, Xuanwu Hospital of Capital Medical University Innovation and application of diagnosis and treatment strategies and key technologies of lupus erythematosus (second prize): Lu Qianjin, Zhao Ming, Dai Yong, Zhang Jianzhong, Xiao Rong, Wu Haijing, Long Hai, Liao Jieyue, Li Yaping, Tang Donge; main completion units: Xiangya Second Hospital of Central South University, Shenzhen People's hospital, Peking University People's Hospital Establishment and application of key technologies for prevention and control of major parasitic diseases such as malaria and schistosomiasis (second prize): Pan Weiqing, Yu xinbing, Li Ming, Zhang Dongmei, Wu Yingsong, Wang Jihua, Xu Xindong, Huang Yan, Hao Wenbo, Kang Keren; mainly completed by: the Second Military Medical University of the people's Liberation Army, Sun Yat sen University, Southern Medical University, Tongji University, Guangzhou DARUI Biotechnology Co., Ltd., Guangzhou Wanfu Biotechnology Co., Ltd the key technology creation and industrialization application of the comprehensive development of traditional Chinese Medicine big variety 37 (second prize) Main completers: Sun Xiaobo, sun guibo, Xu Huibo, Yang Chongren, Zhang Yingjun, Wang Tao, Dong dialect, Chen Zhongjian, LAN Feng, Yu Yuqi; mainly completed by: Institute of medicinal plants, Chinese Academy of Medical Sciences, Jilin University of traditional Chinese medicine, Kunming Institute of plant, Chinese Academy of Sciences, Tianjin University of traditional Chinese medicine, Wenshan Miao Township 37 Co., Ltd., Kunming Shenghuo Pharmaceutical (Group) Co., Ltd., Kunming Pharmaceutical Group Co., Ltd Establishment and clinical application of the treatment technology system of atlantoaxial dislocation with integrated Chinese and Western Medicine (second prize): Tan Mingsheng, Yiping, Hao Qingying, Yang Feng, Wang Wenjun, LV Guohua, Tian Jiwei, Tan Yuanchao, Zhou Yingjie, Wang Guohua Qing Dynasty; mainly completed by: China Japan Friendship Hospital, Luoyang orthopedic hospital of Henan Province (Henan orthopedic hospital), Xiangya No.2 Hospital of Central South University, Wendeng osteosynthesis Hospital of Shandong Province, the first people's Hospital of Shanghai City, the First Affiliated Hospital of Nanhua University, the First Affiliated Hospital of Southwest Medical University (second prize) Main completed by: ye Wencai, Wang Guangji, Wu Xiaoming, fan Chunlin, Wang Ying, Zhang Xiaoqi, Zhang Dongmei, Wang Hao, Liu Donglai, Peihong; main completed by: Jinan University, China Pharmaceutical University, Lizhu group Limin pharmaceutical factory, Guangzhou Kanghe Pharmaceutical Co., Ltd nerve root cervical spondylosis TCM Comprehensive Scheme and technique evaluation system (second prize) Main finishers: Zhu Liguo, Feng Minshan, Yu Jie, Wei Xu, Wang Ping, Li Jinxue, Gao Jinghua, Huang yuancan, sun Shuchun, Yang Kexin; mainly completed by: Wangjing Hospital of the Chinese Academy of traditional Chinese medicine, the First Affiliated Hospital of Tianjin University of traditional Chinese medicine, China Rehabilitation Research Center, Guangdong Hospital of traditional Chinese medicine, Beijing Electric Power Hospital of State Grid Corporation, Yueyang Hospital of integrated traditional and Western Medicine Affiliated to Shanghai University of traditional Chinese medicine, Beijing University of Technology Key technology system construction and industrialization of candesartan ester raw materials and preparations (second prize) mainly completed by: Gao Yongji, Zheng Geng Xiu, Zhang Fu, Cong Rigang, Wang Guan, Zou Yuanhua, Li Zongwen, Liu Bingpeng, long Lianqing, Li Jing; mainly completed by: Disha Pharmaceutical Group Co., Ltd., Jinan University, Shanghai Pharmaceutical Industry Research Institute, weihaidisu Pharmaceutical Co., Ltd Establishment and promotion of key technologies for the evaluation of AIDS diagnosis, treatment and prevention products (second prize): Wang Youchun, Zheng Yongtang, Huang Weijin, Yang LIUMENG, Xu Sihong, Wang Ruirui, Nie Jianhui, Liu Qiang, Luo ronghua, song Aijing; main completion units: China Institute of food and drug control, Kunming Institute of zoology, Chinese Academy of Sciences Key technology development and large-scale industrialization (second prize) of large-scale vascular stent series products: Chang Zhaohua, Li Zhonghua, sun Lizhong, Zhu Qing Dynasty, Yuan Zhenyu, Huang Dingguo, Wang Liwen, Peng Dadong, Lu Hongjie, Xing Zhikai; main completion units: Shanghai minimally invasive medical devices (Group) Co., Ltd., minimally invasive heart pulse medical technology (Shanghai) Co., Ltd., Beijing Anzhen Hospital Affiliated to Capital Medical University new technology of liver transplantation: the establishment and application of spleen fossa heterotopic auxiliary liver transplantation (second prize) Mainly completed by: Dou Kefeng, Tao Kaishan, Yue Shuqiang, Yuan Jianlin, Han Hua, Wang Desheng, Yang Zhaoxu, pan Dengke, Zeng Daiwen, Li Xiao; mainly completed by: the Fourth Military Medical University of the Chinese people's Liberation Army, Beijing Institute of animal husbandry and veterinary medicine of the Chinese Academy of Agricultural Sciences, Sichuan Academy of Medical Sciences and Experimental Animal Research Institute of Sichuan people's Hospital Innovation and promotion of key technologies for diagnosis and treatment of gliomas (second prize): Jiang Tao, you Yongping, Wang Weimin, Kang Chunsheng, Zhang Wei, Qiu Xiaoguang, Li Wenbin, Li Guilin, Li Shaowu, you Jiangxi; main completion units: Beijing Tiantan Hospital Affiliated to Capital Medical University, Jiangsu People's Hospital, Guangzhou General Hospital of Guangzhou Military Region, General Hospital of Tianjin Medical University, Beijing neurosurgery Research Institute, Beijing Shijitan Hospital Affiliated to Capital Medical University, the establishment and application of key technologies of comprehensive prevention and treatment system for gastric cancer (second prize) Main completed by: Ji Jiafu, you Weicheng, Chen Lin, Shen Lin, Liang Han, Lu Youyong, pan Kaifeng, Shou Chengchao, Deng Dajun, Ke Yang; main completed by: Beijing Cancer Hospital, General Hospital of the people's Liberation Army, Tumor Hospital of Tianjin Medical University, people's Hospital of Peking University innovative theory, prevention and application of immune high blindness (second prize) Main finishers: Yang peizeng, Hou Sheng
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.